로딩 중…
지수 로딩 중…
OptimizeRx Corporation
OPRX· NASDAQ· Health Care· Health Care Equipment & Services
$6.55+8.26%
2026-08-03
Financials
Valuation Metrics
OptimizeRx Corporation's Market Cap is $123M. At end of 2025 it was $229M. Ranked #3067 of 3,112 in US market (top 99%), #1406 of 1,445 on NASDAQ (top 97%), #200 of 206 in Health Care Equipment & Services (top 97%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $123M | US#3,067/3,112 Sec#200/206 |
| Revenue | $107M | US#2,771/3,112 Sec#188/206 |
| Net Income | $7M | US#2,174/3,112 Sec#111/206 |
| Total Assets | $167M | US#2,998/3,112 Sec#194/206 |
| Net Assets | $130M | US#2,842/3,112 Sec#185/206 |
| Value | ||
| P/E | 17.98x | US#887/3,112 Sec#17/206 |
| P/B | 0.95x | US#317/3,112 Sec#21/206 |
| P/S | 1.15x | US#751/3,112 Sec#53/206 |
| EV/EBITDA | 6.69x | US#307/3,112 Sec#10/206 |
| FCF Yield | 11.66% | US#386/3,112 Sec#13/206 |
| Profitability | ||
| ROE | 5.27% | US#1,829/3,112 Sec#87/206 |
| ROA | 4.09% | US#1,172/3,112 Sec#73/206 |
| Op. Margin | 13.57% | US#1,325/3,112 Sec#54/206 |
| Revenue Growth | -9.50% | US#2,652/3,112 Sec#191/206 |
| Financial Health | ||
| Debt Ratio | 29.05% | US#324/3,112 Sec#38/206 |
| Total Debt | $24M | US#2,673/3,112 Sec#169/206 |
| FCF | $14M | US#2,180/3,112 Sec#137/206 |
| Cash | $20M | US#2,860/3,112 Sec#191/206 |
| Current Ratio | 5.37x | US#442/3,112 Sec#38/206 |
| Net Debt/EBITDA | 0.19x | US#709/3,112 Sec#45/206 |
| Performance | ||
| 1Y Return | -47.60% | US#2,966/3,112 Sec#193/206 |
| 1M Return | 5.82% | US#874/3,112 Sec#69/206 |
| From 52W High | -70.56% | US#3,027/3,112 Sec#202/206 |
| 1Y MDD | -79.06% | US#3,040/3,112 Sec#198/206 |
| Trading | ||
| Volume | 105,976 shares | US#2,925/3,112 Sec#202/206 |
| Trading Value | $681425.00 | US#3,058/3,112 Sec#201/206 |
| Per Share | ||
| EPS | $0.28 | US#1,944/3,112 Sec#102/206 |
| BPS | $6.87 | US#2,053/3,112 Sec#125/206 |